News Release

Printer Friendly Version View printer-friendly version
<< Back
Download PDF Download PDF
Third Quarter Results for Fiscal 2014
Reiterates FY14 Non-GAAP Diluted EPS Growth Outlook of 6-9% YoY

ST. LOUIS, July 29, 2014 /PRNewswire/ -- 

Key highlights:

  • Third fiscal quarter revenue of $902 million, within the $885-$915 million guidance range. Foreign currency movements positively affected revenue by approximately $3 million relative to the second quarter of fiscal 2014
  • Third fiscal quarter non-GAAP operating income of $151 million; non-GAAP operating margin of 16.7%; GAAP operating income of $125 million
  • Third fiscal quarter diluted non-GAAP EPS of $0.81, within the $0.75-$0.81 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects
  • Diluted GAAP EPS of $0.68 for the third fiscal quarter, within the $0.61-$0.69 guidance range
  • Free cash flow of $173 million for the third fiscal quarter
  • Twelve-month backlog of $2.97 billion at the end of the third fiscal quarter, up $30 million from the end of the second quarter of fiscal 2014
  • Repurchased $93 million of ordinary shares during the third fiscal quarter
  • The board of directors approved a $0.155 per share quarterly cash dividend to be paid on October 17, 2014  
  • Fourth quarter fiscal 2014 guidance: Expected revenue of approximately $890-$920 million.  Expected diluted non-GAAP EPS of approximately $0.75-$0.81, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects.  Expected diluted GAAP EPS of approximately $0.61-$0.69

Amdocs Limited (NASDAQ: DOX) today reported that for its fiscal quarter ended June 30, 2014, revenue was $902.5 million, up 0.6% sequentially from the second fiscal quarter of 2014 and up 7.3% as compared to last year's third fiscal quarter. Net income on a non-GAAP basis was $130.9 million, or $0.81 per diluted share, compared to non-GAAP net income of $134.4 million, or $0.83 per diluted share, in the third quarter of fiscal 2013. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $21.1 million, net of related tax effects, in the third quarter of fiscal 2014 and excludes such amortization and other acquisition related costs and equity-based compensation expenses of $14.9 million, net of related tax effects, in the third quarter of fiscal 2013. The Company's GAAP net income for the third quarter of fiscal 2014 was $109.8 million, or $0.68 per diluted share, compared to GAAP net income of $119.6 million, or $0.73 per diluted share, in the prior fiscal year's third quarter. 

"We are pleased with our third fiscal quarter performance, which reflects healthy customer activity in North America, and sequentially stable revenue in Europe. Additionally, we delivered record revenue in the emerging markets, reflecting the progression of highly complex transformation projects towards production. We are continuously improving our strategic position with some of the leading carriers in Latin America and South East Asia, as demonstrated by Telefónica's recent selection of Amdocs for new quad-play transformation projects in Peru and Chile. Finally, we continue to see encouraging levels of customer engagement in the area of network software, and the post-merger integration of Actix and Celcite within Amdocs is progressing in line with our original expectations", said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, "During the quarter, we continued to support our North American customers in their strategic initiatives. Along these lines, we are today pleased to announce that Bell Canada has selected Amdocs Convergent Charging, powered by our Turbo Charging technology, as its next generation charging solution. This arrangement is enabling support for Bell's converging lines of business and reinforces a long-standing strategic partnership with one of our largest customers."

Gelman said, "In Europe, we made further progress at Vodafone Group where we added another two affiliates to be supported under the global managed services agreement we signed in fiscal 2013.  These include Vodafone's fixed line operations in the UK and the Vodafone Group Enterprise M2M line of operations. We are now supporting seven Vodafone affiliates under this agreement, which we see as evidence of the value that Amdocs' managed services can deliver in Europe as operators seek greater simplicity and improved quality in their IT operations."

Gelman concluded, "As we embark on our fourth fiscal quarter, we remain highly focused on our execution, which includes securing new business, improving our operating efficiency and continuously expanding our product suite with innovative new offerings. We are on-track to deliver full year revenue growth towards the mid-point of our previously guided range of 5% to 8%. This outlook naturally reflects many moving parts, including with respect to consolidation activity amongst North American wireless and Pay TV operators. Our free cash flow generation continues to be robust, and we remain committed towards the balanced allocation of our capital over the long term. Taking all these factors into consideration, we continue to expect diluted non-GAAP earnings per share growth of 6% to 9% for the full fiscal year."

Discussion of Third Fiscal Quarter Financial Results

Free cash flow was $173 million for the quarter, comprised of cash flow from operations of $199 million, less $26 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.97 billion at the end of the third quarter of fiscal 2014. 

Financial Outlook

Amdocs expects that revenue for the fourth quarter of fiscal 2014 will be approximately $890-$920 million. Diluted earnings per share on a non-GAAP basis for the fourth fiscal quarter are expected to be $0.75-$0.81, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the fourth fiscal quarter will be $0.61-$0.69

Quarterly Cash Dividend Program

On July 29, 2014, the Board approved the Company's next quarterly cash dividend payment of $0.155 per share and set September 30, 2014 as the record date for determining the shareholders entitled to receive the dividend, which is payable on October 17, 2014.

Conference Call Details

Amdocs will host a conference call on July 29, 2014 at 5:00 p.m. Eastern Time to discuss the Company's third fiscal quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets and other acquisition related costs;
  • equity-based compensation expense; and
  • tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, equity-based compensation expense and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs

For 30 years, Amdocs has ensured service providers' success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control and optimization product portfolio with value-driven professional services and managed services operations.  With revenue of $3.3 billion in fiscal 2013, Amdocs and its 22,000 employees serve customers in more than 80 countries.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2013 filed on December 9, 2013, our Form 6-K furnished for the first quarter of fiscal 2014 on February 11, 2014 and our Form 6-K furnished for the second quarter of fiscal 2014 on May 15, 2014.

                                               

AMDOCS LIMITED










Consolidated Statements of Income

(in thousands, except per share data)








Three months ended


Nine months ended



June 30,


June 30,



2014


2013


2014


2013








Revenue:









License


$   11,861


$   18,616


$     65,247


$     59,433

Service


890,616


822,716


2,598,129


2,441,196



902,477


841,332


2,663,376


2,500,629

Operating expenses:









Cost of license


639


561


2,235


1,839

Cost of service


583,965


546,108


1,723,056


1,619,215

Research and development


64,863


59,583


190,292


179,002

Selling, general and administrative


112,681


103,396


335,078


313,539

Amortization of purchased intangible
  assets and other

15,326


8,520


43,174


28,358



777,474


718,168


2,293,835


2,141,953

Operating income


125,003


123,164


369,541


358,676










Interest and other expense, net


748


2,726


4,060


4,591

Income before income taxes


124,255


120,438


365,481


354,085










Income taxes


14,428


880


43,862


30,600

Net income


$ 109,827


$ 119,558


$ 321,619


$ 323,485

Basic earnings per share


$       0.69


$       0.74


$       2.02


$       2.00

Diluted earnings per share


$       0.68


$       0.73


$       1.99


$       1.98

Basic weighted average number of shares
  outstanding

159,257


160,914


159,574


161,350

Diluted weighted average number of shares
  outstanding

161,725


162,667


161,939


163,048

Cash dividends declared per share


$     0.155


$     0.130


$     0.440


$     0.390

 

AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)








Three months ended


Nine months ended



June 30,


June 30,



2014


2013


2014


2013










Revenue


$ 902,477


$ 841,332


$ 2,663,376


$ 2,500,629










Non-GAAP operating income

150,849


141,551


446,735


418,935










Non-GAAP net income


130,919


134,430


385,333


373,154










Non-GAAP diluted earnings per
  share

$       0.81


$       0.83


$         2.38


$         2.29










Diluted weighted average number
  of shares outstanding

161,725


162,667


161,939


163,048

 

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)




Three months ended
June 30, 2014



Reconciliation items



GAAP

Amortization of
purchased
intangible assets
and other

Equity based
compensation
expense

Tax effect

Non-GAAP

Operating expenses:






Cost of license

$         639

$                 -

$              -

$               -

$         639

Cost of service

583,965

-

(4,297)

-

579,668

Research and
 
development

64,863

-

(880)

-

63,983

Selling, general and 
 
administrative

112,681

-

(5,343)

-

107,338

Amortization of
 
purchased intangible
  assets and other

15,326

(15,326)

-

-

-

Total operating expenses

777,474

(15,326)

(10,520)

-

751,628







Operating income

125,003

15,326

10,520

-

150,849







Income taxes

14,428

-

-

4,754

19,182







Net income

$ 109,827

$       15,326

$    10,520

$    (4,754)

$   130,919














Three months ended
June 30, 2013



Reconciliation items



GAAP

Amortization of
purchased
intangible assets
and other

Equity based
compensation
expense

Tax effect

Non-GAAP

Operating expenses:






Cost of license

$         561

$                 -

$             -

$             -

$         561

Cost of service

546,108

-

(4,937)

-

541,171

Research and
 
development

59,583

-

(1,060)

-

58,523

Selling, general and 
 
administrative

103,396

-

(3,870)

-

99,526

Amortization of
 
purchased intangible
  assets and other

8,520

(8,520)

-

-

-

Total operating expenses

718,168

(8,520)

(9,867)

-

699,781







Operating income

123,164

8,520

9,867

-

141,551







Income taxes

880

-

-

3,515

4,395







Net income

$ 119,558

$         8,520

$ 9,867

$    (3,515)

$   134,430













 

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)




Nine months ended
June 30, 2014



Reconciliation items



GAAP

Amortization of
purchased
intangible assets
and other

Equity based
compensation
expense

Tax effect

Non-GAAP

Operating expenses:






Cost of license

$     2,235

$                 -

$                 -

$             -

$      2,235

Cost of service

1,723,056

-

(13,220)

-

1,709,836

Research and
 
development

190,292

-

 

(2,685)

-

187,607

Selling, general and 
 
administrative

335,078

-

 

(18,115)

-

316,963

Amortization of
 
purchased intangible
  assets and other

43,174

(43,174)

-

-

-

Total operating expenses

2,293,835

(43,174)

(34,020)

-

2,216,641







Operating income

369,541

43,174

34,020

-

446,735







Income taxes

43,862

-

-

13,480

57,342







Net income

$ 321,619

$       43,174

$       34,020

$ (13,480)

$ 385,333












Nine months ended
June 30, 2013



Reconciliation items



GAAP

Amortization of
purchased
intangible assets
and other

Equity based
compensation
expense

Tax effect

Non-GAAP

Operating expenses:






Cost of license

$     1,839

$                 -

$                 -

$             -

$      1,839

Cost of service

1,619,215

-

(14,440)

-

1,604,775

Research and
 
development

179,002

-

 

(3,060)

-

175,942

Selling, general and
 
administrative

313,539

-

 

(14,401)

-

299,138

Amortization of
 
purchased intangible
  assets and other

28,358

(28,358)

-

-

-

Total operating expenses

2,141,953

(28,358)

(31,901)

-

2,081,694







Operating income

358,676

28,358

31,901

-

418,935







Income taxes

30,600

-

-

10,590

41,190







Net income

$ 323,485

$       28,358

$       31,901

$ (10,590)

$ 373,154






















 

AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(in thousands)




As of



June 30, 
2014


September 30, 
2013






ASSETS










Current assets





Cash, cash equivalents and short-term interest-bearing investments

$      1,174,610


$      1,326,380

Accounts receivable, net, including unbilled of $137,504 and $110,626, 
   respectively

755,622


678,219

Deferred income taxes and taxes receivable


156,809


125,880

Prepaid expenses and other current assets


146,917


151,595

    Total current assets


2,233,958


2,282,074






Equipment and leasehold improvements, net


276,101


275,544

Goodwill and other intangible assets, net


2,127,360


1,975,060

Other noncurrent assets


393,417


393,135

Total assets


$      5,030,836


$      4,925,813






LIABILITIES AND SHAREHOLDERS' EQUITY










Current liabilities





Accounts payable, accruals and other


$         720,300


$         683,768

Short-term financing arrangements


-


200,000

Deferred revenue


212,691


151,112

Deferred income taxes and taxes payable


70,224


39,376

    Total current liabilities


1,003,215


1,074,256

Other noncurrent liabilities


598,160


576,774

Shareholders' equity


3,429,461


3,274,783

Total liabilities and shareholders' equity


$      5,030,836


$      4,925,813

 

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)






Nine months ended June 30,



2014


2013






Cash Flow from Operating Activities:





Net income


$       321,619


$       323,485

Reconciliation of net income to net cash provided by operating activities:




    Depreciation and amortization


116,911


107,400

    Equity-based compensation expense


34,020


31,901

    Deferred income taxes


(5,336)


1,829

Excess tax benefit from equity-based compensation


(574)


(275)

    Loss from short-term interest-bearing investments


737


1,873

Net changes in operating assets and liabilities, net of amounts acquired:




    Accounts receivable


(40,570)


31,559

    Prepaid expenses and other current assets


2,828


(12,010)

    Other noncurrent assets


(17,639)


23,056

    Accounts payable, accrued expenses and accrued personnel

25,955


(59,279)

    Deferred revenue


55,625


(18,360)

    Income taxes payable


5,802


(14,391)

    Other noncurrent liabilities


16,980


22,054

Net cash provided by operating activities


516,358


438,842






Cash Flow from Investing Activities:





Payments for purchase of equipment and leasehold improvements, net

(77,881)


(80,151)

Proceeds from sale of short-term interest-bearing investments

284,926


258,121

Net cash paid for acquisitions


(180,540)


-

Purchase of short-term interest-bearing investments


(294,091)


(324,982)

Other


3,348


(4,161)

Net cash used in investing activities


(264,238)


(151,173)






Cash Flow from Financing Activities:





Payments under financing arrangements


(200,000)


(200,000)

Repurchase of shares


(261,916)


(270,251)

Proceeds from employee stock options exercised


116,041


154,105

Payments of dividends


(66,363)


(63,079)

Payments under capital lease and other


(136)


(825)

Net cash used in financing activities


(412,374)


(380,050)






Net decrease in cash and cash equivalents


(160,254)


(92,381)

Cash and cash equivalents at beginning of period


1,014,192


879,158

Cash and cash equivalents at end of period


$       853,938


$       786,777






 

AMDOCS LIMITED

Supplementary Information

(in millions)






Three months ended



June 30,
2014


March 31,
2014


December 31,
2013


September 30,
2013


June 30,
2013

North America

$      647.2


$      651.7


$      628.0


$      608.9


$      619.2

Europe

114.6


113.8


117.0


101.9


98.0

Rest of the World

140.7


131.4


119.0


134.4


124.1

Total Revenue

$      902.5


$      896.9


$      864.0


$      845.2


$      841.3














As of



June 30,
2014


March 31,
2014


December 31,
2013


September 30,
2013


June 30,
2013

Emerging Markets Revenue

$      116.9


$      103.4


$      100.7


$      113.8


$      101.3














As of



June 30,
2014


March 31,
2014


December 31,
2013


September 30,
2013


June 30,
2013

Managed Services Revenue

$      438.0


$      426.3


$      429.3


$      414.0


$      417.1














Three months ended



June 30,
2014


March 31,
2014


December 31,
2013


September 30,
2013


June 30,
2013

Customer Experience
Systems

$      870.8


$      863.6


$      829.6


$      809.3


$      803.2

Directory

31.7


33.3


34.4


35.9


38.1

Total Revenue

$      902.5


$      896.9


$      864.0


$      845.2


$      841.3














As of



June 30,
2014


March 31,
2014


December 31,
2013


September 30,
2013


June 30,
2013

12-Month Backlog

$      2,970


$      2,940


$      2,890


$      2,870


$      2,830

 

 

SOURCE Amdocs

Matthew Smith, Director, Investor Relations, Amdocs, 314-212-8328, E-mail: dox_info@amdocs.com